Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010
about
Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceImpact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infectionReclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals.Evolving character of chronic central nervous system HIV infection.Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced diseaseHeme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders.Microbial translocation in the pathogenesis of HIV infection and AIDS.Efficient use of longitudinal CD4 counts and viral load measures in survival analysis.Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.Study design issues in evaluating immune biomarkers.Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.The Association between Yang-Deficient Constitution and Clinical Outcome of Highly Active Antiretroviral Therapy on People Living with HIV.Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection.Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV InfectionHIV as a Cause of Immune Activation and Immunosenescence.Changes in inflammation but not in T cell activation precede non-AIDS-defining events in a case-control study of patients on long-term antiretroviral therapy.Tuberculosis and HIV Coinfection.p24 revisited: a landscape review of antigen detection for early HIV diagnosis
P2860
Q26825762-E3C265E0-3F5E-49D9-85BE-C499C4AA35D7Q28481938-EBA009E9-0307-476E-8673-BECA22ED293EQ33917180-AE8785E6-FE28-40B0-B266-2290873F436AQ33995713-8E38FE91-293C-4EDE-8648-09C02C3E19C2Q34100037-A8D9253F-D8D9-4EA7-AC58-BFF6C01F3D02Q34139883-4DB03014-015F-445A-83A2-F5BAF83B6D1FQ36558287-2F2A798B-4662-4EDB-9E3E-4F1F74A0BB6AQ36811161-D7CFB5DF-3B43-4977-8182-51C9E7D5CB18Q37122279-0C391236-26C7-4928-BB3E-6D0D093B14E7Q37184783-5F122201-3F4B-47B1-827A-AE63C5ACF9D1Q37295610-1B1E6000-510F-45FE-B3A8-DC6EE5816B10Q37483020-79A7B5F9-E3E1-4692-A9CA-55F4DE2002E6Q37619346-9AD56E50-5387-4864-B85F-34D4D34FCA27Q38128778-A4F826FE-7C78-4EE5-824E-88249F91CAECQ38603237-4FCAB70D-A417-4460-BD65-38FBB1BD0BB3Q40692524-EB65B902-86DD-406A-A8FC-50846B4AE9F8Q47151081-27C7AB2A-F6A9-4E03-9D4D-CF9761A4FACDQ50138604-B7DC6D8B-A378-4BFE-8279-A16AEEB91CD8Q51054145-4FCE2642-3D49-4D78-883C-F780D2D616B8Q57150995-CC00174B-1FBE-4561-8BE3-9DB19F9B1C77
P2860
Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Soluble biomarkers and morbidi ...... shed reports from 1997 to 2010
@ast
Soluble biomarkers and morbidi ...... shed reports from 1997 to 2010
@en
Soluble biomarkers and morbidi ...... hed reports from 1997 to 2010.
@nl
type
label
Soluble biomarkers and morbidi ...... shed reports from 1997 to 2010
@ast
Soluble biomarkers and morbidi ...... shed reports from 1997 to 2010
@en
Soluble biomarkers and morbidi ...... hed reports from 1997 to 2010.
@nl
prefLabel
Soluble biomarkers and morbidi ...... shed reports from 1997 to 2010
@ast
Soluble biomarkers and morbidi ...... shed reports from 1997 to 2010
@en
Soluble biomarkers and morbidi ...... hed reports from 1997 to 2010.
@nl
P2860
P1476
Soluble biomarkers and morbidi ...... shed reports from 1997 to 2010
@en
P2093
Jacqueline Neuhaus
James D Neaton
P2860
P304
P356
10.1097/COH.0B013E32833ED75D
P50
P577
2010-11-01T00:00:00Z